References
- Mete O, Kilicaslan I, Gulluoglu M G, Uysal V. Can renal oncocytoma be differentiated from its renal mimics? The utility of anti-mitochondrial, caveolin-1, CD63 and cytokeratin 14 antibodies in the differential diagnosis. Virchows Arch 2005; 447: 938–946
- Abrahams N A, MacLennan G T, Khoury J D, et al. Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue micoarray. Histopathology 2004; 45: 593–602
- Avery A K, Beckstead J, Renshaw A A, Corless C L. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am J Surg Pathol 2000; 24: 203–210
- Kim M K, Kim S. Immunohistochemical profile of common epithelial neoplasms arising in the kidney. Appl Immunohistochem Mol Morphol 2002; 10: 332–338
- Langner C, Ratschek M, Rehak P, et al. CD10 is a diagnostic andprognostic marker in renal malignancies. Histopathology 2004; 45: 460–467
- Martignoni G, Pea M, Brunelli M, et al. CD10 expression in a subset ofchromophobe renal cell carcinomas. Mod Pathol 2004; 17: 1455–1463
- Mazal P R, Stichenwirth M, Koller A, et al. Expression of aquaporins and PAX-2 compared to CD10 and cytokeratin 7 in renal neoplasms: a tissue microarray study. Mod Pathol 2005; 18: 535–540
- Pan C C, Chen P CH, Ho D MT. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases. Histopathology 2004; 45: 452–459
- Wang H Y, Mills S. KIT and RCC are useful in distinguishing chromophobe RCC from the granular variant of clear cell RCC. Am J Surg Pathol 2005; 29: 640–646
- Liu L, Qian J, Singh H, et al. Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: An optimal and practical panel for differential diagnosis. Arch Pathol Lab Med 2007; 131: 1290–1297